Source:http://linkedlifedata.com/resource/pubmed/id/12388504
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2002-10-21
|
pubmed:abstractText |
OBJECTIVE: Systemic mastocytosis is a hematologic neoplasm characterized by abnormal accumulation and growth of mast cells in one or more organ systems. We analyzed five patients with systemic mastocytosis referred for FDG positron emission tomography who had biopsy-proven mast cell infiltrates in various organs. CONCLUSION: Our findings indicate that FDG positron emission tomography is not useful for staging and follow-up of aggressive systemic mastocytosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0361-803X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
179
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1235-7
|
pubmed:dateRevised |
2008-2-15
|
pubmed:meshHeading |
pubmed-meshheading:12388504-Adult,
pubmed-meshheading:12388504-Female,
pubmed-meshheading:12388504-Fluorodeoxyglucose F18,
pubmed-meshheading:12388504-Humans,
pubmed-meshheading:12388504-Male,
pubmed-meshheading:12388504-Mastocytosis,
pubmed-meshheading:12388504-Middle Aged,
pubmed-meshheading:12388504-Neoplasm Staging,
pubmed-meshheading:12388504-Radiopharmaceuticals,
pubmed-meshheading:12388504-Tomography, Emission-Computed
|
pubmed:year |
2002
|
pubmed:articleTitle |
FDG positron emission tomography in patients with systemic mastocytosis.
|
pubmed:affiliation |
Department of Nuclear Medicine, University of Vienna, Währinger Gürtel 18-20, A-1090 Wien, Austria.
|
pubmed:publicationType |
Journal Article
|